Trademark: 97178326
Word
MANDOS
Status
Pending
Status Code
731
Status Date
Friday, February 16, 2024
Serial Number
97178326
Mark Type
4000
Filing Date
Friday, December 17, 2021
Published for Opposition
Tuesday, January 10, 2023

Trademark Owner History
Mandos LLC - Owner At Publication

Classifications
5 pharmaceutical preparations for the prevention and treatment of a variety of ailments and conditions, namely, acute bronchitis, allergies, arthritis, asthma, cancer, cellulitis, cirrhosis, common cold, cold sore, conjunctivitis, cystitis, diabetes, diarrhea, ear infection, fever, fibromyalgia, fungal infection, gastroenteritis, headaches, hemorrhoids, high cholesterol, hyperglycemia, hypoglycemia, indigestion, irritable bowel syndrome, influenza, laryngitis, lyme disease, meningitis, mononucleosis, osteoporosis, pneumonia, pyelonephritis, rosacea, sinusitis, skin abscess, stomach aches, and streptococcal pharyngitis
36 Business brokerage services and related consulting pertaining to business sales, mergers, acquisitions and business valuations; Intellectual property venture fund management services; Holding company services performed for third parties, namely, investment management
45 Licensing of intellectual property
10 Medical devices for the purposes of lowering cholesterol
MAN DOS
The English translation of "Mandos" in the mark is "Controls" or "Commands".

Trademark Events
Feb 17, 2024
Notice Of Approval Of Extension Request E-Mailed
Feb 16, 2024
Sou Extension 2 Granted
Feb 16, 2024
Sou Extension 2 Filed
Feb 16, 2024
Sou Teas Extension Received
Sep 28, 2023
Notice Of Approval Of Extension Request E-Mailed
Sep 28, 2023
Corrected Noa E-Mailed
Sep 27, 2023
Sou Extension 1 Granted
Sep 7, 2023
Sou Extension 1 Filed
Sep 27, 2023
Divisional Processing Complete
Sep 7, 2023
Divisional Request Received
Sep 7, 2023
Teas Request To Divide Received
Sep 18, 2023
Case Assigned To Intent To Use Paralegal
Sep 7, 2023
Sou Teas Extension Received
Mar 7, 2023
Noa E-Mailed - Sou Required From Applicant
Jan 10, 2023
Official Gazette Publication Confirmation E-Mailed
Jan 10, 2023
Published For Opposition
Dec 21, 2022
Notification Of Notice Of Publication E-Mailed
Dec 7, 2022
Approved For Pub - Principal Register
Dec 7, 2022
Examiner's Amendment Entered
Dec 7, 2022
Notification Of Examiners Amendment E-Mailed
Dec 7, 2022
Examiners Amendment E-Mailed
Dec 7, 2022
Examiners Amendment -Written
Nov 9, 2022
Teas/Email Correspondence Entered
Nov 9, 2022
Correspondence Received In Law Office
Nov 9, 2022
Assigned To Lie
Sep 26, 2022
Teas Response To Office Action Received
Sep 23, 2022
Notification Of Non-Final Action E-Mailed
Sep 23, 2022
Non-Final Action E-Mailed
Sep 23, 2022
Non-Final Action Written
Sep 23, 2022
Assigned To Examiner
Jan 20, 2022
Teas Change Of Correspondence Received
Jan 20, 2022
Attorney/Dom.Rep.Revoked And/Or Appointed
Jan 20, 2022
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Dec 22, 2021
New Application Office Supplied Data Entered
Dec 21, 2021
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24